otitis media vaccine (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameotitis media vaccine (GlaxoSmithKline)

Drug Alias Nameotitis media vaccine (Cortecs)H influenzae + M cattarhalis vaccine (Cortecs)H influenzae + M cattarhalis vaccine(GlaxoSmithKline)H influenzae + M cattarhalis vaccine (SmithKline Beecham)vaccine (OMP26 antigen)(Smithkline Beecham) +[8]

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsOtitis Media

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New ZealandUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProvalis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Canberra Provalis Glaxosmithkline Plc +[4]

Active IndicationsN/A

Inactive IndicationsOtitis Media

Other Information

ATC CodeN/A